EVIDENCE LIBRARY
Did a Cocaine Vaccine Prevent High-Dose Effects in People?
An experimental cocaine vaccine, dAd5GNE, was tested against repeated cocaine exposure in animals. The researchers studied daily-use models in mice and African green monkeys, and a high-dose “binge” model in mice. Those models address whether antibodies can limit cocaine’s access to the central nervous system under more challenging exposure patterns.
What the animal experiments found
Vaccination limited central cocaine access in the daily-use models. In the high-dose mouse model, it reduced cocaine-related hyperactivity and the number of seizures. These are preclinical findings under controlled dosing and vaccination conditions.
The human evidence boundary
The paper mentions a newly initiated clinical trial, but does not report human trial outcomes. Animal protection does not establish that the vaccine prevents intoxication, overdose, or return to use in people. Antibody response, safety, duration and effectiveness in real-world exposure remain clinical questions.
Source: Havlicek DF et al., PLOS ONE (2020), 15:e0239780. doi:10.1371/journal.pone.0239780.